Sun Pharmaceutical Industries, reportedly, is recalling 200 vials of the chemotherapy drug gemcitabine in the United States (US) due to a lack of assurance of sterility. The drug being recalled was manufactured by Sun Pharma's unit Caraco Pharmaceutical Laboratories at its plant in Gujarat.
Meanwhile, the voluntary recall was initiated in April and was classified by the FDA as Class II, implying that use of or exposure to the recalled drug may cause temporary or medically reversible adverse health consequences.
Lastly, this marks Sun Pharma's second drug recall this year. In January, the company started a voluntary recall of about 2,528 bottles of its generic version of diabetes drug Glumetza, after it received a customer complaint that one of the bottles contained tablets of an epilepsy drug.
Sun Pharmaceutical Industries is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1532.85 |
Dr. Reddys Lab | 5812.50 |
Cipla | 1403.90 |
Zydus Lifesciences | 1104.45 |
Lupin | 1661.90 |
View more.. |